Hydroxyzine Pamoate 25 mg Capsule, 60-count
🆔 Identity & classification
Where does this data come from?
🏷️ RxNorm drug class
This medicine belongs to the Antihistamine class.
Where does this data come from?
🏭 Manufacturer & labeler
Where does this data come from?
🩺 Clinical
Hydroxyzine is used to relieve itching caused by allergic skin reactions, to relieve anxiety and tension, and as a sedative before and after general anesthesia for surgery. Hydroxyzine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms. It also works by decreasing activity in the brain.
Read the full MedlinePlus article ↗- Hydroxyzine is most often used to relieve anxiety and tension, or to control itching from allergic conditions like hives or eczema. It's also used as a calming medication before su...
- Drowsiness is the most common side effect — it's actually how the medication works, so some sleepiness is expected, especially when you first start. For most people it gets better...
- This is really important to go over with your pharmacist or doctor, because hydroxyzine interacts with a number of common drugs. Combining it with alcohol, opioid pain medicines, s...
- Can I take hydroxyzine with my other medications?
Patient education
Supplement & herbal interactions
Where does this data come from?
Ask a licensed pharmacist directly — free, answered by our team.
💊 What it looks like
Where does this data come from?
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII 35SW5USQ3G
A synthetic yellow dye used to color medicines. It helps make tablets, capsules, and liquids visually distinct so patients can easily identify their medication.
-
UNII H3R47K3TBD
FD&C Blue No. 1 is a synthetic blue dye approved for use in foods and medicines. It serves as a colorant to give the medication its distinctive appearance and help with product identification.
-
UNII WZB9127XOA
A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
-
UNII H77VEI93A8
A synthetic yellow dye used to color medications. It helps identify the drug and make it visually distinctive, with no effect on how the medicine works.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII 368GB5141J
A detergent and foaming agent derived from coconut or palm oil. In medications, it helps break down and mix oil and water-based ingredients, aids in tablet disintegration, and improves how the drug dissolves and spreads in the mouth or digestive system.
-
UNII 5856J3G2A2
A starch-based powder made from potatoes and processed with sodium. It acts as a disintegrant, helping the tablet or capsule break apart quickly in the stomach so the medicine can be absorbed.
-
UNII O8232NY3SJ
A plant-based carbohydrate derived from corn kernels. It acts as a filler to add bulk, a binder to hold ingredients together, and a disintegrant to help the tablet break apart in your stomach for absorption.
9 inactive ingredients listed in the exact product block matched to this NDC.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · Q2 2026 | $0.1145 | $6.87 / 60 capsules |
Where does this data come from?
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Hydroxyzine Pamoate 25 mg 00115-1803-01 | Amneal | 100 capsules | $0.063 | AB | Availability likely | — |
| hydroxyzine pamoate 25 mg 00185-0674-01 | Sandoz | 100 capsules | $0.063 | AB | Availability likely | — |
| Hydroxyzine Pamoate 25 mg 00555-0323-02 | Teva | 100 capsules | $0.063 | AB | Availability likely | — |
| hydroxyzine pamoate 25 mg 00904-7065-61 | Major | 100 capsules | $0.063 | AB | Availability likely | — |
| hydroxyzine pamoate 25 mg 14539-0674-01 | Heritage | 100 capsules | $0.063 | AB | Availability likely | — |
| Hydroxyzine Pamoate 25 mg 50268-0398-50 | AvPAK | 50 capsules | $0.063 | AB | Availability likely | — |
| Hydroxyzine Pamoate 25 mg 60687-0696-01 | American | 100 capsules | $0.063 | AB | Availability likely | — |
| Hydroxyzine pamoate 25 mg 62135-0816-12 | Chartwell | 120 capsules | $0.063 | AB | Availability likely | — |
| Hydroxyzine Pamoate 25 mg 00615-8419-39 | NCS | 30 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 43063-0172-01 | PD-Rx | 100 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 43063-0406-01 | PD-Rx | 100 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 50090-4385-02 | A-S | 20 capsules | — | AB | FDA listed | — |
| Hydroxyzine Pamoate 25 mg 50090-4579-02 | A-S | 20 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 51407-0001-01 | Golden | 100 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 51655-0847-20 | Northwind | 20 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 55154-2337-00 | Cardinal | 10 capsules | — | AB | FDA listed | — |
| Hydroxyzine Pamoate 25 mg 61919-0880-15 | Direct_Rx | 15 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 63629-8874-01 | Bryant | 500 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 63629-9612-01 | Bryant | 100 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 67046-0281-03 | Coupler | 30 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 67046-2086-03 | Coupler | 30 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 68071-2255-02 | NuCare | 20 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 68071-3736-01 | NuCare | 100 capsules | — | AB | FDA listed | — |
| Hydroxyzine Pamoate 25 mg 68071-4915-03 | NuCare | 30 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 68071-4954-03 | NuCare | 30 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 68788-7767-01 | Preferred | 100 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 68788-8119-01 | Preferred | 100 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 70518-0209-00 | REMEDYREPACK | 30 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 70518-1504-00 | REMEDYREPACK | 30 capsules | — | AB | FDA listed | — |
| Hydroxyzine Pamoate 25 mg 71205-0087-15 | Proficient | 15 capsules | — | AB | FDA listed | — |
| Hydroxyzine Pamoate 25 mg 71205-0123-15 | Proficient | 15 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 71205-0433-30 | Proficient | 30 capsules | — | AB | FDA listed | — |
| Hydroxyzine Pamoate 25 mg 71205-0483-30 | Proficient | 30 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 71205-0558-30 | Proficient | 30 capsules | — | AB | FDA listed | — |
| Hydroxyzine Pamoate 25 mg 71335-0998-01 | Bryant | 20 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 71335-1325-01 | Bryant | 20 capsules | — | AB | Discontinued | — |
| hydroxyzine pamoate 25 mg 71335-1714-01 | Bryant | 20 capsules | — | AB | FDA listed | — |
| Hydroxyzine Pamoate 25 mg 71335-2187-01 | Bryant | 20 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 71335-2751-01 | Bryant | 30 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 71335-3003-01 | Bryant | 30 capsules | — | AB | FDA listed | — |
| Hydroxyzine Pamoate 25 mg 71610-0217-30 | Aphena | 30 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 71610-0747-30 | Aphena | 30 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 71610-0773-30 | Aphena | 30 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 71610-0883-30 | Aphena | 30 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 72162-1054-03 | Bryant | 30 capsules | — | AB | FDA listed | — |
| Hydroxyzine Pamoate 25 mgthis 72189-0009-60 | Direct_Rx | 60 capsules | — | AB | FDA listed | — |
| Hydroxyzine Pamoate 25 mg 76420-0920-01 | Asclemed | 100 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 82982-0032-30 | Pharmasource | 30 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 87441-0040-01 | Unit | 30 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 51655-0725-52 | Northwind | 30 capsules | — | AB | FDA listed | — |
| hydroxyzine pamoate 25 mg 87441-0087-01 | Unit | 30 capsules | — | AB | FDA listed | — |
Where does this data come from?
⏳ Availability & generic status
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
📊 Medicare Part D spend CMS · PART D · 2026 (Q1)
🔬 Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 72189-0009-30 | 30 CAPSULE in 1 BOTTLE (72189-009-30) | 2019-06-26 | Inactivated by FDA |
| 72189-0009-15 | 15 CAPSULE in 1 BOTTLE (72189-009-15) | 2019-06-26 | Active |
| 72189-0009-60 You're viewing this | 60 CAPSULE in 1 BOTTLE (72189-009-60) | 2019-06-26 | Active |
You're viewing the largest of 3 pack sizes for this product.
Pack size FAQ
What quantity is in NDC 72189-0009-60?
What is the difference between NDC 72189-0009-60 and NDC 72189-0009-15?
What NDC number is used to bill for this package of Hydroxyzine Pamoate 25 mg Capsule?
🧭 About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | ✓ Available |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
Questions about this listing
Why is there no price listed?
Is the NDC printed on the package the same as the 11-digit billing NDC?
What do the three segments of this NDC mean?
Is this package still being marketed?
Does this product come in other package sizes?
Who lists this product with the FDA?
Do I need a prescription for this product?
Where does this data come from?
📄 Full prescribing information FDA SPL
🎯 Indications and Usage ▾
For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritus. As a sedative when used as premedication and following general anesthesia, Hydroxyzine may potentiate meperidine (Demerol®) and barbiturates, so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis.
Atropine and other belladonna alkaloids are not affected by the drug. Hydroxyzine is not known to interfere with the action of digitalis in any way and it may be used concurrently with this agent. The effectiveness of hydroxyzine as an antianxiety agent for long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies.
The physician should reassess periodically the usefulness of the drug for the individual patient.
⛔ Contraindications ▾
Hydroxyzine, when administered to the pregnant mouse, rat, and rabbit, induced fetal abnormalities in the rat and mouse at doses substantially above the human therapeutic range. Clinical data in human beings are inadequate to establish safety in early pregnancy. Until such data are available, hydroxyzine is contraindicated in early pregnancy.
Hydroxyzine is contraindicated in patients with a prolonged QT interval. Hydroxyzine pamoate is contraindicated for patients who have shown a previous hypersensitivity to any component of this medication. Hydroxyzine is contraindicated in patients with known hypersensitivity to hydroxyzine products, and in patients with known hypersensitivity to cetirizine hydrochloride or levocetirizine hydrochloride.
⚠️ Warnings ▾
Nursing Mothers It is not known whether this drug is excreted in human milk. Since many drugs are so excreted, hydroxyzine should not be given to nursing mothers.
🤒 Adverse Reactions ▾
Side effects reported with the administration of hydroxyzine pamoate are usually mild and transitory in nature. Skin and Appendages: Oral hydroxyzine hydrochloride is associated with Acute Generalized Exanthematous Pustulosis (AGEP) and fixed drug eruptions in post-marketing reports. Anticholinergic: Dry mouth.
Central Nervous System: Drowsiness is usually transitory and may disappear in a few days of continued therapy or upon reduction of the dose. Involuntary motor activity, including rare instances of tremor and convulsions, has been reported, usually with doses considerably higher than those recommended. Clinically significant respiratory depression has not been reported at recommended doses.
Cardiac System: QT prolongation, Torsade de Pointes. In post-marketing experience, the following additional undesirable effects have been reported: Body as a Whole: allergic reaction, Nervous System: headache, Psychiatric: hallucination, Skin and Appendages: pruritus, rash, urticaria. To report SUSPECTED ADVERSE REACTIONS, contact Heritage Pharmaceuticals at 1-866-901-DRUG (3784) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
🆘 Overdosage ▾
The most common manifestation of overdosage of hydroxyzine pamoate is hypersedation. Other reported signs and symptoms were convulsions, stupor, nausea and vomiting. As in the management of overdosage with any drug, it should be borne in mind that multiple agents may have been taken.
If vomiting has not occurred spontaneously, it should be induced. Immediate gastric lavage is also recommended. General supportive care, including frequent monitoring of the vital signs and close observation of the patient, is indicated.
Hypotension, though unlikely, may be controlled with intravenous fluids and vasopressors (do not use epinephrine as hydroxyzine counteracts its pressor action.) Caffeine and Sodium Benzoate Injection, USP, may be used to counteract central nervous system depressant effects. Hydroxyzine overdose may cause QT prolongation and Torsade de Pointes. ECG monitoring is recommended in cases of hydroxyzine overdose.
There is no specific antidote. It is doubtful that hemodialysis would be of any value in the treatment of overdosage with hydroxyzine. However, if other agents such as barbiturates have been ingested concomitantly, hemodialysis may be indicated.
There is no practical method to quantitate hydroxyzine in body fluids or tissue after its ingestion or administration. DOSAGE For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested: in adults, 50–100 mg q.i.d.; children under 6 years, 50 mg daily in divided doses; and over 6 years, 50–100 mg daily in divided doses. For use in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritus: in adults, 25 mg t.i.d. or q.i.d.; children under 6 years, 50 mg daily in divided doses; and over 6 years, 50–100 mg daily in divided doses.
As a sedative when used as a premedication and following general anesthesia: 50–100 mg in adults, and 0.6 mg/kg in children. When treatment is initiated by the intramuscular route of administration, subsequent doses may be administered orally. As with all medications, the dosage should be adjusted according to the patient's response to therapy.
🧬 Clinical Pharmacology ▾
Hydroxyzine pamoate is unrelated chemically to the phenothiazines, reserpine, meprobamate, or the benzodiazepines. Hydroxyzine pamoate is not a cortical depressant, but its action may be due to a suppression of activity in certain key regions of the subcortical area of the central nervous system. Primary skeletal muscle relaxation has been demonstrated experimentally.
Bronchodilator activity, and antihistaminic and analgesic effects have been demonstrated experimentally and confirmed clinically. An antiemetic effect, both by the apomorphine test and the veriloid test, has been demonstrated. Pharmacological and clinical studies indicate that hydroxyzine in therapeutic dosage does not increase gastric secretion or acidity and in most cases has mild antisecretory activity.
Hydroxyzine is rapidly absorbed from the gastrointestinal tract and hydroxyzine pamoate's clinical effects are usually noted within 15 to 30 minutes after oral administration.
📦 How Supplied / Storage and Handling ▾
Hydroxyzine Pamoate Capsules (hydroxyzine pamoate equivalent to hydroxyzine hydrochloride) are available as: 25 mg capsules: Hard gelatin capsules, green opaque cap, green opaque body, cap and body imprinted EP136 in black ink. They are supplied as follows: Bottles of 100: Bottles of 500: 50 mg capsules: Hard gelatin capsules, white opaque cap, green opaque body, cap and body imprinted EP112 in black ink. They are supplied as follows: Bottles of 100: Bottles of 500: Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature].
Dispense in tight, light resistant containers (USP). Manufactured by: Heritage Pharma Labs Inc. East Brunswick, NJ 08816 1.866.901.DRUG (3784) [Image] 51U000000293US03 Revised: 04/2019
📋 Description ▾
Hydroxyzine pamoate is a light yellow odorless powder, practically insoluble in water and methanol and freely soluble in dimethylformamide. It is chemically designated as (±)-2-[2-[4-(p-Chloro-α-phenylbenzyl)-1-piperazinyl]ethoxy]ethanol 4,4 -methylenebis[3-hydroxy-2-naphthoate] (1:1) and can be structurally represented as follows: [structure] Chemical Formula: C21H27ClN2O2.C23H16O6 Molecular Weight: 763.29 Inert ingredients for the capsule formulations are: hard gelatin capsules (which contain gelatin, titanium dioxide, FD&C Blue #1, FD&C Red #40, D&C Yellow #10), printing ink which contains shellac glaze ~45% (20% esterified) in Ethanol, iron oxide black, n-butyl alcohol, isopropyl alcohol, propylene glycol and ammonium hydroxide 28%); magnesium stearate, microcrystalline cellulose, pregelatinized starch, sodium lauryl sulfate, sodium starch glycolate.